This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
TCR DO11.10 Monoclonal Antibody (KJ1-26 (KJ126, KJI-26, KJI26)), FITC, eBioscience
catalog :
11-5808-82
quantity :
100 ug
price :
US 158.00
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
KJ1-26 (KJ126, KJI-26, KJI26)
reactivity :
mouse
application :
flow cytometry
citations: 48
Reference |
---|
Wang Y, Wang Y, Wang Y, Zheng G, Tan T, Lee S, et al. Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis. Int J Clin Exp Pathol. 2014;7:38-47 pubmed
|
Rudulier C, Kroeger D, Bretscher P. The activation, by antigen, of naïve TCR transgenic CD4 T cells cultured at physiological, rather than artificially high, frequencies more accurately reflects the in vivo activation of normal numbers of naïve CD4(+) T cells. Cell Immunol. 2012;274:115-20 pubmed publisher
|
Gorfu G, Rivera Nieves J, Ley K. Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med. 2009;9:836-50 pubmed
|
Saito K, Torii M, Ma N, Tsuchiya T, Wang L, Hori T, et al. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol. 2008;181:6889-97 pubmed
|
Mamchak A, Sullivan B, Hou B, Lee L, Gilden J, Krummel M, et al. Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells. J Immunol. 2008;181:5374-85 pubmed
|
Burbach B, Srivastava R, Medeiros R, O Gorman W, Peterson E, Shimizu Y. Distinct regulation of integrin-dependent T cell conjugate formation and NF-kappa B activation by the adapter protein ADAP. J Immunol. 2008;181:4840-51 pubmed
|
McKinley L, Alcorn J, Peterson A, Dupont R, Kapadia S, Logar A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181:4089-97 pubmed
|
Lee S, Prince J, Rais M, Kheradmand F, Ballantyne C, Weitz Schmidt G, et al. Developmental control of integrin expression regulates Th2 effector homing. J Immunol. 2008;180:4656-67 pubmed
|
Blazquez A, Berin M. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J Immunol. 2008;180:4441-50 pubmed
|
Coombes J, Siddiqui K, Arancibia Cárcamo C, Hall J, Sun C, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757-64 pubmed
|
Wang Z, Davies J. CD8 blockade promotes antigen responsiveness to nontolerizing antigen in tolerant mice by inhibiting apoptosis of CD4+ T cells. J Immunol. 2007;178:6148-57 pubmed
|
Moulton V, Bushar N, Leeser D, Patke D, Farber D. Divergent generation of heterogeneous memory CD4 T cells. J Immunol. 2006;177:869-76 pubmed
|
Marski M, Kandula S, Turner J, Abraham C. CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J Immunol. 2005;175:7889-97 pubmed
|
Shin T, Yoshimura K, Shin T, Crafton E, Tsuchiya H, Housseau F, et al. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med. 2005;201:1531-41 pubmed
|
Thorstenson K, Herzovi L, Khoruts A. A model of suppression of the antigen-specific CD4 T cell response by regulatory CD25+CD4 T cells in vivo. Int Immunol. 2005;17:335-42 pubmed
|
Yasumi T, Katamura K, Okafuji I, Yoshioka T, Meguro T, Nishikomori R, et al. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J Immunol. 2005;174:1325-31 pubmed
|
Sinha P, Clements V, Ostrand Rosenberg S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol. 2005;174:636-45 pubmed
|
product information
Product Type :
Antibody
Product Name :
TCR DO11.10 Monoclonal Antibody (KJ1-26 (KJ126, KJI-26, KJI26)), FITC, eBioscience
Catalog # :
11-5808-82
Quantity :
100 ug
Price :
US 158.00
Clonality :
Monoclonal
Purity :
Affinity chromatography
Host :
Mouse
Reactivity :
Mouse
Applications :
Flow Cytometry: 0.125 ug/test
Species :
Mouse
Clone :
KJ1-26 (KJ126, KJI-26, KJI26)
Isotype :
IgG2a, kappa
Storage :
4 C, store in dark, DO NOT FREEZE!
Description :
TCR DO11 (DO11.10) is a receptor found on lymphocytes of DO11.10 transgenic mice and T-cell receptors of BALB/c-derived DO11.10 and DO11.10.24 T cell hybridomas. The DO11.10 TCR recognizes a C-terminal ovalbumin peptide (OVA 323-339) in the context of I-Ad major histocompatibility molecules. The use of antibodies against DO11.10 have proven to be instrumental in describing many of the intricate details of T cell immunity, including T cell activation, development, and function.
Format :
Liquid
Applications w/Dilutions :
Flow Cytometry: 0.125 ug/test
Aliases :
D011.10; T cell receptor alpha chain; Tcra; Tcralpha
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments